Hill Stephen's most recent trade in Lyell Immunopharma Inc was a trade of 8,000 Common Stock done . Disclosure was reported to the exchange on Aug. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2025 | 8,000 | 16,849 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.54 per share. | 20 Aug 2025 | 1,004 | 15,845 | - | 10.5 | 10,586 | Common Stock |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.34 per share. | 11 Aug 2025 | 94 | 8,849 | - | 10.3 | 972 | Common Stock |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.53 per share. | 11 Aug 2025 | 91 | 8,943 | - | 10.5 | 958 | Common Stock |
| AvalonBay Communities - REIT | Stephen P. Hills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 971 | 8,780 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Hill Stephen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 172,899 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Hill Stephen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| AvalonBay Communities - REIT | Stephen P. Hills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 980 | 7,576 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 48,928 | - | 0 | Common Stock | |
| AvalonBay Communities - REIT | Stephen P. Hills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 990 | 6,380 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 900,000 | 900,000 | - | - | Option (right to buy) | |
| AvalonBay Communities - REIT | Stephen P. Hills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 852 | 5,217 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Technical Ops. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 700,000 | 700,000 | - | - | Option (right to buy) | |
| AvalonBay Communities - REIT | Stephen P. Hills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 833 | 4,264 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Lipocine Inc | Stephen A. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 7,500 | 12,750 (0%) | 0% | 0 | Common Stock | |
| Lipocine Inc | Stephen A. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 7,500 | 7,500 | - | - | Restricted Stock Unit |